Clinical efficacy analysis of paxlovid in children with hematological diseases infected with the omicron SARS-CoV-2 new variant

DOI record: { "DOI": "10.3389/fped.2023.1160929", "ISSN": [ "2296-2360" ], "URL": "http://dx.doi.org/10.3389/fped.2023.1160929", "abstract": "<jats:sec><jats:title>Objective</jats:title><jats:p>To summarize the clinical characteristics of children with hematological malignancies co-infected with novel coronavirus and explore the safety and effectiveness of Paxlovid treatment.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>From December 10, 2022, to January 20, 2023, the clinical data of children with hematological diseases diagnosed with novel coronavirus infection in the outpatient and emergency department of the Seventh Affiliated Hospital of Sun Yat-sen University were retrospectively analyzed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>According to whether to give paxlovid or not, it is divided into group A (paxlovid group) and group B (non-paxlovid group). The length of fever was 1–6 days in group A and 0–3 days in group B. The viral clearance time was shorter in group A than in group B. The inflammatory indexes CRP and PCT were significantly higher in group A than in group B (<jats:italic>P </jats:italic>&amp;lt; 0.05). Twenty patients were followed up for 1 month after leaving the hospital, and there were 5 cases of reappearance of fever, 1 case of increased sleep, 1 case of physical fatigue and 1 case of loss of appetite within 2 weeks.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Paxlovid has no apparent adverse reactions in children 12 years old and younger with underlying hematological diseases infected with the new coronavirus. Focusing on the interaction between paxlovid and other drugs is necessary during the treatment.</jats:p></jats:sec>", "alternative-id": [ "10.3389/fped.2023.1160929" ], "author": [ { "affiliation": [], "family": "Li", "given": "Yixian", "sequence": "first" }, { "affiliation": [], "family": "Liu", "given": "Yong", "sequence": "additional" }, { "affiliation": [], "family": "Wen", "given": "Luping", "sequence": "additional" }, { "affiliation": [], "family": "Chen", "given": "Hui", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Wenqing", "sequence": "additional" }, { "affiliation": [], "family": "Tian", "given": "Mengyao", "sequence": "additional" }, { "affiliation": [], "family": "Cheng", "given": "Yucai", "sequence": "additional" }, { "affiliation": [], "family": "Xue", "given": "Hongman", "sequence": "additional" }, { "affiliation": [], "family": "Chen", "given": "Chun", "sequence": "additional" } ], "container-title": "Frontiers in Pediatrics", "container-title-short": "Front. Pediatr.", "content-domain": { "crossmark-restriction": true, "domain": [ "frontiersin.org" ] }, "created": { "date-parts": [ [ 2023, 4, 25 ] ], "date-time": "2023-04-25T05:17:40Z", "timestamp": 1682399860000 }, "deposited": { "date-parts": [ [ 2023, 4, 25 ] ], "date-time": "2023-04-25T05:17:45Z", "timestamp": 1682399865000 }, "indexed": { "date-parts": [ [ 2023, 4, 26 ] ], "date-time": "2023-04-26T05:09:39Z", "timestamp": 1682485779979 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2023, 4, 25 ] ] }, "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 4, 25 ] ], "date-time": "2023-04-25T00:00:00Z", "timestamp": 1682380800000 } } ], "link": [ { "URL": "https://www.frontiersin.org/articles/10.3389/fped.2023.1160929/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "1965", "original-title": [], "prefix": "10.3389", "published": { "date-parts": [ [ 2023, 4, 25 ] ] }, "published-online": { "date-parts": [ [ 2023, 4, 25 ] ] }, "publisher": "Frontiers Media SA", "reference": [ { "DOI": "10.3390/vaccines10101751", "article-title": "Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and vaccine effectiveness", "author": "Tulimilli", "doi-asserted-by": "publisher", "journal-title": "Vaccines (Basel)", "key": "B1", "volume": "10", "year": "2022" }, { "DOI": "10.1016/j.micres.2022.127204", "article-title": "Omicron variant: current insights and future directions", "author": "Rana", "doi-asserted-by": "publisher", "first-page": "127204", "journal-title": "Microbiol Res", "key": "B2", "volume": "265", "year": "2022" }, { "DOI": "10.1016/j.healun.2020.03.012", "article-title": "COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal", "author": "Siddiqi", "doi-asserted-by": "publisher", "first-page": "405", "journal-title": "J Heart Lung Transplant", "key": "B3", "volume": "39", "year": "2020" }, { "DOI": "10.1016/j.envres.2020.109819", "article-title": "Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy", "author": "Jayaweera", "doi-asserted-by": "publisher", "first-page": "109819", "journal-title": "Environ Res", "key": "B4", "volume": "188", "year": "2020" }, { "DOI": "10.1007/s42979-022-01015-1", "article-title": "IoT-Based smart health monitoring system for COVID-19", "author": "Bhardwaj", "doi-asserted-by": "publisher", "first-page": "137", "journal-title": "SN Comput Sci", "key": "B5", "volume": "3", "year": "2022" }, { "DOI": "10.1080/07853890.2022.2031274", "article-title": "Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines", "author": "Fernandes", "doi-asserted-by": "publisher", "first-page": "524", "journal-title": "Ann Med", "key": "B6", "volume": "54", "year": "2022" }, { "DOI": "10.1093/cid/ciac443", "article-title": "Effectiveness of paxlovid in reducing severe COVID-19 and mortality in high risk patients", "author": "Najjar-Debbiny", "doi-asserted-by": "publisher", "journal-title": "Clin Infect Dis", "key": "B7", "volume": "76", "year": "2022" }, { "DOI": "10.1056/NEJMoa2118542", "article-title": "Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19", "author": "Hammond", "doi-asserted-by": "publisher", "first-page": "1397", "journal-title": "N Engl J Med", "key": "B8", "volume": "386", "year": "2022" }, { "DOI": "10.1093/cid/ciac180", "article-title": "Molnupiravir and nirmatrelvir-ritonavir: oral coronavirus disease 2019 antiviral drugs", "author": "Saravolatz", "doi-asserted-by": "publisher", "first-page": "165", "journal-title": "Clin Infect Dis", "key": "B9", "volume": "76", "year": "2023" }, { "DOI": "10.15585/mmwr.mm7125e2", "article-title": "Hospitalization and emergency department encounters for COVID-19 after paxlovid treatment—california, December 2021-may 2022", "author": "Malden", "doi-asserted-by": "publisher", "first-page": "830", "journal-title": "MMWR Morb Mortal Wkly Rep", "key": "B10", "volume": "71", "year": "2022" }, { "DOI": "10.21037/atm-22-2791", "article-title": "The feasibility, safety, and efficacy of paxlovid treatment in SARS-CoV-2-infected children aged 6-14 years: a cohort study", "author": "Yan", "doi-asserted-by": "publisher", "first-page": "619", "journal-title": "Ann Transl Med", "key": "B11", "volume": "10", "year": "2022" }, { "key": "B12", "year": "2019" }, { "DOI": "10.1016/j.cej.2022.138822", "article-title": "An ultra-sensitive and specific nanoplasmonic-enhanced isothermal amplification platform for the ultrafast point-of-care testing of SARS-CoV-2", "author": "Liu", "doi-asserted-by": "publisher", "first-page": "138822", "journal-title": "Chem Eng J", "key": "B13", "volume": "451", "year": "2023" }, { "DOI": "10.6004/jnccn.2022.0052", "article-title": "NCCN Guidelines® insights: survivorship, version 1.2022", "author": "Sanft", "doi-asserted-by": "publisher", "first-page": "1080", "journal-title": "J Natl Compr Canc Netw", "key": "B14", "volume": "20", "year": "2022" }, { "DOI": "10.5395/rde.2017.42.2.152", "article-title": "Statistical notes for clinical researchers: chi-squared test and Fisher's Exact test", "author": "Kim", "doi-asserted-by": "publisher", "first-page": "152", "journal-title": "Restor Dent Endod", "key": "B15", "volume": "42", "year": "2017" }, { "DOI": "10.3760/cma.j.issn.0253-2727.2020.12.001", "article-title": "Chinese Guidelines for the clinical application of antibacterial drugs for agranulocytosis with fever (2020)", "doi-asserted-by": "publisher", "first-page": "969", "journal-title": "Zhonghua Xue Ye Xue Za Zhi", "key": "B16", "volume": "41", "year": "2020" }, { "DOI": "10.1136/archdischild-2020-320338", "article-title": "Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections", "author": "Zimmermann", "doi-asserted-by": "publisher", "journal-title": "Arch Dis Child", "key": "B17", "year": "2020" }, { "DOI": "10.1016/j.cell.2021.01.007", "article-title": "Adaptive immunity to SARS-CoV-2 and COVID-19", "author": "Sette", "doi-asserted-by": "publisher", "first-page": "861", "journal-title": "Cell", "key": "B18", "volume": "184", "year": "2021" }, { "DOI": "10.3389/fped.2021.773895", "article-title": "Late effects after haematopoietic stem cell transplantation in ALL, long-term follow-up and transition: a step into adult life", "author": "Diesch-Furlanetto", "doi-asserted-by": "publisher", "first-page": "773895", "journal-title": "Front Pediatr", "key": "B19", "volume": "9", "year": "2021" }, { "DOI": "10.1186/s40560-014-0048-1", "article-title": "Concurrent treatment with a tumor necrosis factor-alpha inhibitor and veno-venous extracorporeal membrane oxygenation in a post-hematopoietic stem cell transplant patient with idiopathic pneumonia syndrome: a case report", "author": "Koinuma", "doi-asserted-by": "publisher", "first-page": "48", "journal-title": "J Intensive Care", "key": "B20", "volume": "2", "year": "2014" }, { "DOI": "10.1016/j.ejca.2021.09.027", "article-title": "SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: an analysis of 131 patients", "author": "Haeusler", "doi-asserted-by": "publisher", "first-page": "78", "journal-title": "Eur J Cancer", "key": "B21", "volume": "159", "year": "2021" }, { "DOI": "10.1007/s00431-022-04615-4", "article-title": "Guidelines for the prevention and management of children and adolescents with COVID-19", "author": "Levy", "doi-asserted-by": "publisher", "first-page": "4019", "journal-title": "Eur J Pediatr", "key": "B22", "volume": "181", "year": "2022" }, { "DOI": "10.1056/NEJMoa2203315", "article-title": "Evaluation of mRNA-1273 COVID-19 vaccine in children 6 to 11 years of age", "author": "Creech", "doi-asserted-by": "publisher", "first-page": "2011", "journal-title": "N Engl J Med", "key": "B23", "volume": "386", "year": "2022" }, { "DOI": "10.1007/s40121-022-00729-2", "article-title": "Efficacy and safety of nirmatrelvir/ritonavir, molnupiravir, and remdesivir in a real-world cohort of outpatients with COVID-19 at high risk of progression: the PISA outpatient clinic experience", "author": "Tiseo", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Infect Dis Ther", "key": "B24", "volume": "12", "year": "2022" }, { "DOI": "10.15585/mmwr.mm7148e2", "article-title": "Paxlovid associated with decreased hospitalization rate among adults with COVID-19—united States, April-September 2022", "author": "Shah", "doi-asserted-by": "publisher", "first-page": "1531", "journal-title": "MMWR Morb Mortal Wkly Rep", "key": "B25", "volume": "71", "year": "2022" }, { "DOI": "10.1038/s41375-022-01578-1", "article-title": "Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European conference on infections in leukaemia (ECIL 9)", "author": "Cesaro", "doi-asserted-by": "publisher", "first-page": "1467", "journal-title": "Leukemia", "key": "B26", "volume": "36", "year": "2022" }, { "DOI": "10.1111/bjh.17547", "article-title": "COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience", "author": "Lucchini", "doi-asserted-by": "publisher", "first-page": "e74", "journal-title": "Br J Haematol", "key": "B27", "volume": "194", "year": "2021" }, { "DOI": "10.1002/pbc.28514", "article-title": "COVID-19 in pediatric hematopoietic stem cell transplantation: the experience of spanish group of transplant (GETMON/GETH)", "author": "Vicent", "doi-asserted-by": "publisher", "first-page": "e28514", "journal-title": "Pediatr Blood Cancer", "key": "B28", "volume": "67", "year": "2020" }, { "DOI": "10.1016/j.nmni.2022.100985", "article-title": "Does ivermectin have a place in the treatment of mild COVID-19?", "author": "Schwartz", "doi-asserted-by": "publisher", "first-page": "100985", "journal-title": "New Microbes New Infect", "key": "B29", "volume": "46", "year": "2022" }, { "DOI": "10.3389/fped.2022.935118", "article-title": "Case report: application of nirmatrelvir/ritonavir to treat COVID-19 in a severe aplastic anemia child after allogeneic hematopoietic stem cell transplantation", "author": "Huang", "doi-asserted-by": "publisher", "first-page": "935118", "journal-title": "Front Pediatr", "key": "B30", "volume": "10", "year": "2022" }, { "DOI": "10.1097/FTD.0000000000000761", "article-title": "Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions", "author": "Elens", "doi-asserted-by": "publisher", "first-page": "360", "journal-title": "Ther Drug Monit", "key": "B31", "volume": "42", "year": "2020" }, { "DOI": "10.1111/tid.12751", "article-title": "Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4", "author": "Groll", "doi-asserted-by": "publisher", "journal-title": "Transpl Infect Dis", "key": "B32", "volume": "19", "year": "2017" }, { "DOI": "10.1016/j.bj.2020.11.005", "article-title": "Lopinavir/ritonavir: repurposing an old drug for HIV infection in COVID-19 treatment", "author": "Magro", "doi-asserted-by": "publisher", "first-page": "43", "journal-title": "Biomed J", "key": "B33", "volume": "44", "year": "2021" }, { "DOI": "10.1111/ajt.13111", "article-title": "Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir", "author": "Badri", "doi-asserted-by": "publisher", "first-page": "1313", "journal-title": "Am J Transplant", "key": "B34", "volume": "15", "year": "2015" }, { "DOI": "10.1002/14651858.CD007893.pub2", "article-title": "Effect of cyclosporine on blood pressure", "author": "Robert", "doi-asserted-by": "publisher", "first-page": "Cd007893", "journal-title": "Cochrane Database Syst Rev", "key": "B35", "volume": "1", "year": "2010" }, { "DOI": "10.1097/FTD.0000000000001014", "article-title": "Therapeutic drug monitoring and dosage adjustments of immunosuppressive drugs when combined with nirmatrelvir/ritonavir in patients with COVID-19", "author": "Lemaitre", "doi-asserted-by": "publisher", "first-page": "191", "journal-title": "Ther Drug Monit", "key": "B36", "volume": "45", "year": "2022" }, { "DOI": "10.1002/lt.20165", "article-title": "Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients", "author": "Vogel", "doi-asserted-by": "publisher", "first-page": "939", "journal-title": "Liver Transpl", "key": "B37", "volume": "10", "year": "2004" } ], "reference-count": 37, "references-count": 37, "relation": {}, "resource": { "primary": { "URL": "https://www.frontiersin.org/articles/10.3389/fped.2023.1160929/full" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Pediatrics, Perinatology and Child Health" ], "subtitle": [], "title": "Clinical efficacy analysis of paxlovid in children with hematological diseases infected with the omicron SARS-CoV-2 new variant", "type": "journal-article", "update-policy": "http://dx.doi.org/10.3389/crossmark-policy", "volume": "11" }